Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
M-VISTA with Alb-PRF vs CTG for Gingival Recession
NCT06643507Phase 3Recruiting
- Sponsor
- Cairo University
- Start
- Apr 2025
- Primary completion
- Dec 2026
- Modality
- Hydrogel Systems, Cell Therapies
- Countries
- 1
01
Overview
A Phase 3 trial of albumin + platelet-rich fibrin in gingival recession, sponsored by Cairo University. Started Apr 2025; status: recruiting.
02
Drugs
albumin + platelet-rich fibrin
03
Conditions
gingival recession
Beyond the preview
Go deeper on NCT06643507.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06643507.